HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ischemia- and reperfusion-induced arrhythmias: beneficial actions of nifedipine.

Abstract
The effects of nifedipine against ischemia- and reperfusion-induced arrhythmias were investigated using anesthetized rats with transient coronary artery occlusion. Nifedipine (5 micrograms/kg i.v.) administered 10 min prior to occlusion significantly decreased the incidence of arrhythmias occurring during 20-min coronary occlusion. The incidence and duration of reperfusion-induced ventricular fibrillation and subsequent mortality following 5-min coronary occlusion were also significantly reduced by this intervention. However, administration of nifedipine 1 min prior to reperfusion afforded no protection against reperfusion arrhythmias. To investigate whether nifedipine possesses a true antiarrhythmic action or merely extends the ischemic duration prior to reperfusion resulting in maximal rhythm disturbances, reperfusion was initiated after 3, 5, 7, 10, 20, and 30 min of ischemia. Nifedipine reduced the incidence of reperfusion-induced ventricular fibrillation after all ischemic intervals, with no change in the time of peak vulnerability to reperfusion arrhythmias. Measurements of coronary flow with 153Gadolinium microspheres indicated that flow within ischemic tissue relative to that in normal tissue was significantly increased by nifedipine. Thus, administration of nifedipine prior to occlusion affords a protective effect against ischemia- and reperfusion-induced arrhythmias, and this action is not due to extension of the ischemic duration prior to reperfusion resulting in maximal rhythm disturbances.
AuthorsR Crome, D J Hearse, A S Manning
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) 1986 Nov-Dec Vol. 8 Issue 6 Pg. 1249-56 ISSN: 0160-2446 [Print] United States
PMID2434754 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nifedipine
Topics
  • Animals
  • Arrhythmias, Cardiac (drug therapy, etiology, physiopathology)
  • Blood Pressure (drug effects)
  • Coronary Circulation (drug effects)
  • Coronary Disease (complications)
  • Electrocardiography
  • Heart Rate (drug effects)
  • Male
  • Nifedipine (therapeutic use)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: